For the full year 2024, preliminary revenues from royalties and streams reached a record $262.2 million (US$191.2 million) and preliminary cost of sales (excluding depletion) are estimated at $9.3 ...

The US commercial insurance sector saw a composite rate increase of 2.64% in Q4 2024, bringing the total increase for the ...

With tripling its volumes, Veriff continues to enable trusted online engagements across the globeNew York, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Veriff, a global identity verification and authentication ...

Fortive Corporation (FTV), valued at $26.5 billion by market cap, is a key player in the industrial technology and ...

Osisko Gold Royalties Ltd (the “Company” or “Osisko”) (OR: TSX & NYSE) is pleased to provide an update on its fourth quarter 2024 preliminary deliveries, revenues and cash margin, as well as on its ...

Indian corporates have reported weak quarterly earnings in FY25, with Q2 being particularly poor. Experts anticipate only ...

A final clinical study protocol for DefenCath in Total Parenteral Nutrition (TPN) was submitted to FDA in Q4, and study enrollment is expected to begin in H1 2025. The Company also expects patient ...

InPost Group saw record UK volumes in Q4 2024, delivering 27.2 million parcels, marking a 58% increase year-on-year.

Citing preliminary unaudited results on Tuesday, Verona Pharma (NASDAQ:VRNA) reported ~$36M and $42M in net product sales for Q4 and the full year 2024, respectively, thanks to its newly launched lung ...

Nearly 1 in 5 new car buyers face $1,000+ monthly payments in Q4 2024 as rising loan amounts and high interest rates strain ...

Global venture funding in 2024 edged above 2023’s totals, with AI showing the biggest leap in amounts year to year. Overall ...

The company also anticipates fourth quarter 2024 adjusted EBITDA to exceed $12 million, indicating a move towards profitability. CorMedix CEO Joe Todisco stated, "I'm proud to announce our preliminary ...